Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 8, Issue 2
Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
XML
Oncolytic and local immunotherapy
Original research
Neospora caninum:
a new class of biopharmaceuticals in the therapeutic arsenal against cancer
Online download statistics by month:
Online download statistics by month: November 2020 to April 2022
Abstract
Full
Pdf
Nov 2020
15
15
2
Dec 2020
363
363
163
Jan 2021
97
97
42
Feb 2021
71
71
37
Mar 2021
66
66
32
Apr 2021
53
53
19
May 2021
29
29
22
Jun 2021
55
55
16
Jul 2021
45
45
24
Aug 2021
54
57
18
Sep 2021
49
50
28
Oct 2021
72
72
49
Nov 2021
71
71
52
Dec 2021
39
41
22
Jan 2022
41
46
16
Feb 2022
31
36
12
Mar 2022
61
63
59
Apr 2022
56
58
27
Total
1268
1288
640
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF